Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2021) 73 AEP193 | DOI: 10.1530/endoabs.73.AEP193

ECE2021 Audio Eposter Presentations Diabetes, Obesity, Metabolism and Nutrition (223 abstracts)

Comparative analysis of the methods for differential diagnosis of non-diabetic hypoglycemia (NDH): Beta-hydroxybutyrate and glucagon test

Marina Yukina , Nurana Nuralieva & Ekaterina Troshina


Endocrinology Research Centre, Moscow, Russian Federation


Introduction

some authors propose to conduct consistently two additional tests for differential diagnosis (DD) of NDH with the main purpose to confirm or exclude the autonomous hyperinsulinemia (AH; insulinoma): determination the capillary beta-hydroxybutyrate (BHB) during prolonged fasting test (FT), and glucagon test (GT) at the moment of hypoglycemia. GT is more labor-intensive, high-cost and lead to potential complications. Therefore, we assumed that the BHB determination alone is enough for NDH DD.

Objectives

To compare the efficiency of GT and BHB determination in AH diagnosis.

Methods

In 59 patients aged 44 (23, 74) years with suspected NDH we conducted FT (was interrupted if glycaemia ≤ 2.8 mmol/l with symptoms of neuroglycopenia or, if maintaining normoglycemia, after 72 h). At the end of FT BHB was determined, then GT was conducted: 1 mg of glucagon was administrated iv with venous blood sampling for glucose through 3, 5, 10, 15, 20, 30 min. BHB ≤ 2.7 mmol/l and increase in glycemia ≥ 1.4 mmol/l during GT confirmed AH, opposite results indicated hypoinsulinemia.

Results

63% (n = 37) of patients had hyperinsulinemia (group 1); 37% (n = 22) – hypoinsulinemia/not confirmed NDH (group 2). BHB was 0.2 [0.1; 0.3] mmol/l in group 1; 4.4 [2.3; 4.9] mmol/l in group 2, P < 0.001. Sensitivity, specificity, accuracy of method were: 97.3%, 72.7%, 88.1%, accordingly. ROC-analysis indicated the excellent quality of model: AUC 0.989 [0.967; 1.000]. All patients with false positive results (1.85 [1.60; 2.00] mmol/l; n = 6) had insulin resistance (HOMA-IR > 2.7), that likely blocked ketogenesis. False negative result (3.3 mmol/l) identified in one patient with exacerbation of pyelonephritis, associated with increased ketogenesis. Increase in glycemia after glucagon administration was 2.8 [2.0; 3.4] mmol/l in group 1; 0.8 [0.6; 1.1] mmol/l in group 2, P < 0.001. Sensitivity, specificity, accuracy of method were: 94.6%, 100%, 96.6%, accordingly. ROC-analysis indicated the excellent quality of model: AUC 0.974 [0.937; 1.000]. False negative results (1.03 and 0.68 mmol/l; n = 2), presumably, were due to the influence of any other hormones on the glucagon effect on liver. Results of BHB determination and GT were identical in 90% of cases.

Conclusion

BHB determination and GT are highly sensitive and highly specific methods DD of NDH at the laboratory stage, with a small advantage for GT. But GT is more labor-intensive, high-cost and lead to potential complications. We assume that BHB determination during FT (especially at the end) is mandatory; GT should be used in doubtful cases as an additional method.

Funding

Russian Science Foundation (project 17-75-30035).

Volume 73

European Congress of Endocrinology 2021

Online
22 May 2021 - 26 May 2021

European Society of Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.